Introduction
Over the past 10 years the number of lung transplants performed on an annual basis has consistently risen, with over 3,200 patients transplanted in 2009, at over 125 international centers. 1 Pre-transplant conditioning is an important predictor of morbidity and mortality in these patients, 2, 3 and almost all centers require lung transplant candidates to participate in pulmonary rehabilitation prior to transplant. Patients must have a degree of illness that warrants listing and lung transplantation; however, deteriorating clinical status prior to transplantation may significantly decrease the likelihood of transplant success and survival. 1, 4, 5 The subset of patients who become critically ill and require mechanical ventilation prior to lung transplantation have significantly lower survival, with a decrease in overall 1 year survival rate from 80% to 63.7%. 1 The relative risk of death in patients requiring life support pretransplantation is 1.57 (95% CI 1.31-1.88) in the year following transplant, when compared to those patients who do not require pre-operative life support. 1 Mortality is even higher in critically ill patients who continue to deteriorate and require extracorporeal membrane oxygenation (ECMO) prior to transplantation. [5] [6] [7] [8] As reported outcomes in patients supported pre-transplantation with ECMO are poor, the use of ECMO as a bridge to lung transplantation has been quite limited. 1, 4, [8] [9] [10] [11] SEE THE RELATED EDITORIAL ON PAGE 1388 Mortality in transplant patients supported with ECMO is often related to the degree of organ dysfunction, but an important additional contributor is pre-transplant deconditioning. 2, 3 This deconditioning, while commonplace in critically ill patients, is often further exacerbated in those patients who require ECMO secondary to cannulation techniques, immobility, and sedation practices. 12 Recently published data by Fuehner et al demonstrated improved survival in patients bridged to lung transplant with an "awake ECMO" strategy, when compared to those managed with conventional mechanical ventilation, 13 showing the potential advantages of minimizing sedation. Beyond minimizing sedation, aggressive early rehabilitation is the next step to potentially further improve outcomes in patients being supported with ECMO as a bridge to lung transplantation. [14] [15] [16] This early conditioning is now possible with the introduction of double lumen veno-venous ECMO cannulae and the increasing portability of ECMO technology. 14, [17] [18] [19] [20] The safety of rehabilitation on ECMO has now been reported by several centers. 15, 16, 21, 22 While early rehabilitation has been demonstrated to improve outcomes in the setting of critical illness, 12, [23] [24] [25] [26] the impact of rehabilitation of patients supported with ECMO pre-transplant is unclear. In this report we describe the impact of increased activity and ambulation on patients supported with ECMO as a bridge to lung transplantation.
Methods
With institutional review board approval, we retrospectively identified all patients who received a lung transplant after bridging support with ECMO at Duke University Medical Center. The medical records of these subjects were reviewed with attention to demographics, underlying comorbidities, hospital course, mechanical ventilation modes and strategies, laboratory values, adjunctive therapies, ECMO course and complications, transplant details, and outcomes, including stay, health status at discharge, and 1-year survival. ECMO subjects who received active rehabilitation and ambulation were compared to those subjects who were bridged with ECMO but did not receive pre-transplant rehabilitation. Data between cohorts were compared using the Wilcoxon rank sums test. P values Ͻ .05 were considered significant.
Our rehabilitation protocol has been previously described by Turner et al. 16 In brief, rehabilitation began with resistance and stretching exercises, then progressed to sitting, standing, and, ultimately, ambulation. Sessions occurred twice per day, as tolerated by the subject. Staffing during these sessions generally consisted of an ECMO specialist, a respiratory therapist, 2 physical therapists, and 1-2 bedside nurses. Each provider was assigned a specific role, to ensure safety, including one provider dedicated to support and monitor ECMO cannula position.
Results
We identified 9 consecutive subjects who were bridged to lung transplant with ECMO, all between April 2007 and May 2012. Subjects receiving rehabilitation during ECMO were transplanted between January 2010 and May 2012. Table 1 summarizes key demographic features of the 9 transplant recipients included in this study. Primary diag-
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Current knowledge
Patients with end-stage lung disease often progress to critical illness, dramatically reducing survival following lung transplant. Pre-transplant deconditioning negatively impacts outcomes in lung transplant patients.
What this paper contributes to our knowledge
Bridging selected critically ill patients to transplant with extracorporeal membrane oxygenation (ECMO) is a viable treatment option, and physical therapy, including ambulation, may hasten post-transplantation recovery. noses were typical of other patients requiring lung transplantation. Mean age (45 y vs 28 y, P ϭ .50) and Acute Physiology and Chronic Health Evaluation III score (57.8 vs 86.4, P ϭ .30) were not statistically different between the control cohort (subjects 1-4) and the rehabilitation cohort (subjects 5-9). Subjects 6, 7, and 8 required highfrequency ventilation prior to ECMO cannulation, while subjects 6, 8, and 9 demonstrated systemic inflammatory response physiology at the time of ECMO cannulation.
ECMO and Respiratory Support
All subjects were bridged to transplant with venovenous ECMO, and all were managed in either the cardiothoracic ICU or pediatric ICU during their ECMO course. Subjects in the control cohort were cannulated using a dual cannula technique, using one cannula for venous drainage to the pump and a second cannula for return of oxygenated blood to the subject. Each subject required at least one femoral vein cannulation, with a second cannula in either the right internal jugular vein or the other femoral vein. ECMO for these subjects utilized the Sorin SCP centrifugal pump (Sorin Groups, Arvada, Colorado) with an oxygenator (Safeline Quadrox D, Maquet, Wayne, New Jersey). Subjects in the rehabilitation cohort were all cannulated percutaneously via the right internal jugular vein, using a single, newly available, 19 -27 French dual lumen cannula (Avalon Laboratories, Rancho Domingo, California), placed with the assistance of either fluoroscopy or transesophageal echocardiography. These subjects were maintained on ECMO with a centrifugal pump (Rotaflow, Maquet, Wayne, New Jersey) and oxygenator (Bioline Quadrox D, Maquet, Wayne, New Jersey).
All 9 subjects were anticoagulated for ECMO using unfractionated heparin, with goal activated clotting times of 160 -180 seconds. The activated clotting time goal was lowered to 140 -160 seconds for those subjects with tracheostomy or cannula site bleeding (subjects 5 and 9). While the subjects did receive bolus paralytics for procedures (eg, tracheostomy placement), no subjects were maintained on paralytic infusions during their ECMO course. All subjects in the control cohort were maintained on mechanical ventilation and sedation while on ECMO awaiting transplant. No formal sedation protocol was used.
No subject had serious complications from ECMO. Subject 1 was noted to have elevated liver enzymes, which resolved after transplantation. Subject 7 had a right internal jugular hematoma that was deemed clinically unimportant. Other key ECMO characteristics are summarized in Table 2 .
Surgical tracheostomies were placed in control cohort subjects within the first 9 days following lung transplantation. In comparison, 4 of the rehabilitation cohort subjects (5, 6, 8, and 9) received percutaneous tracheostomies prior to lung transplantation within the first 30 hours following ECMO cannulation. Heparin infusion was held approximately 2 hours prior to and 2 hours after the procedure for each subject. Subject 5 had moderate superficial bleeding post-procedure, and subject 9 required subsequent cauterization of a thyroid laceration, but no other important complications were noted in any of these 4 subjects post-tracheostomy. Subjects 5 and 8 were weaned to humidified oxygen delivered by tracheostomy collar prior to ambulation, while subjects 6 and 9 ambulated while connected to a transport ventilator (Vela, Avea/CareFusion, San Diego, California) on pressure support ventilation, with pressure support of 16 -18 cm H 2 O, PEEP of 6 -10 cm H 2 O, and F IO 2 of 0.4 -0.5. Subject 7 was extubated on ECMO to noninvasive ventilation (BiPAP Vision, Philips Respironics, Murrysville, Pennsylvania) with inspiratory pressure of 12 cm H 2 O, expiratory pressure of 
Rehabilitation
Nutrition was provided to all subjects via gastrojejunostomy tubes. Subjects in the control cohort were sedated for the duration of their support with mechanical ventilation and ECMO and did not participate in physical therapy or rehabilitation during this time. Following ECMO cannulation and stabilization, sedation was minimized for subjects in the rehabilitation cohort, to allow participation in rehabilitation. Ventilator support was also weaned in these subjects, tolerating oxygen saturations greater than 85%.
All subjects in the rehabilitation cohort began actively participating in physical therapy within 5 days of ECMO cannulation, 3 within the first 48 hours. Four of 5 subjects ambulated on ECMO; subject 8 ambulated approximately 213 m, and subject 9 ambulated over 396 m in one rehabilitation session. Subject 7 received his transplant early in his ECMO course, after participating in physical therapy (resistance exercises and sitting on edge of bed) but prior to attempted ambulation. On average, subjects receiving rehabilitation received longer courses of mechanical ventilation and ECMO prior to lung transplantation, likely secondary to delayed listing for transplant during the rehabilitation process.
Transplant
Eight subjects underwent bilateral orthotopic lung transplant. Subject 2 received a lobar transplant, due to size mismatch. All subjects were supported with ECMO for their lung transplantation, with the exception of subject 4, who was transitioned to cardiopulmonary bypass for the procedure, due to surgeon preference. Subject 1 required 4 days of post-transplant ECMO, subjects 2 and 8 were decannulated from ECMO at time of transplant, and all other subjects were removed from ECMO within 24 hours after transplant. Immunosuppressant protocols were the same for all 9 subjects.
Outcomes
One-year survival for subjects 1-8 was 100%. Subject 9 was alive at the time of the submission of this paper, at 4 months post-transplant. Post-transplant duration of ventilation, post-transplant ICU stay, post-transplant hospital stay, total ICU stay, and total hospital stay were all shorter for subjects receiving rehabilitation. Key subject outcomes are summarized in Tables 3 and 4 . Subject 4 required resection of an infarcted right middle lobe prior to discharge. Subject 3 died at 50 months post-transplant, from colon cancer. Subject 5 required single lung retransplantation for graft failure at 234 days for chronic rejection, and died at 16 months post-initial transplantation. Subject 8 died at 17 months post-transplant, also from complications of chronic rejection.
All subjects were on room air at discharge, and there were no notable differences in 3-or 12-month FEV 1 values. No subjects had focal neurologic deficits at discharge; however, subjects 2, 3, and 4 were diagnosed with critical illness neuromyopathy, compared to none of the subjects receiving rehabilitation. Electromyography was performed on any subject with concerns for weakness: electromyography on subject 2 demonstrated a proximal myopathy, subject 3 a proximal myopathy and polyneuropathy, subject 4 a diffuse myopathy, and normal findings for subject 5. Subject 2 was discharged to an in-patient rehabilitation facility, due to her substantial deconditioning, while all other subjects were discharged home with scheduled out-patient rehabilitation.
Discussion
Critical illness dramatically decreases the likelihood of successful lung transplantation, 4, 7, 28 such that support with mechanical ventilation and/or ECMO are relative contraindications to lung transplantation in some centers. 29 Despite the severity of critical illness in the subjects included in this study, 1 year post-transplant survival was 100%, demonstrating that bridging subjects to lung transplantation with ECMO may be a viable option for selected critically ill patients with end-stage lung disease. While several other studies have shown success using ECMO as a bridge to transplant, 9, 13, 21, 30 this is the first series to show comparison data using a novel rehabilitation and ambulation strategy for these critically ill subjects.
This report has several limitations, most notably, the small sample size and retrospective data collection from a single institution. It is difficult to compare subgroups within this population, because of potential selection bias, confounders, and small numbers. Of note, 4 of 5 rehabilitation subjects had cystic fibrosis as the primary diagnosis, compared to 1 of 4 subjects receiving traditional ECMO. While not statistically different, the rehabilitation subjects also had an apparent younger mean age (28 years vs 45 years), but also had a higher mean Acute Physiology and Chronic Health Evaluation III score (86.4 vs 57.8) and a longer mean pre-transplant ECMO course (9 d vs 2 d). As surgical techniques, nutritional support, post-transplant care, immunosuppressant regimens, and other medical management were largely unchanged during this time period, it is feasible the transition to an active rehabilitation approach prior to transplant directly affected the outcome differences seen between these patient groups. The positive effects of pre-transplant conditioning have previously been well documented, with patients receiving lung transplantation after prolonged mechanical ventilation, 29, 31 suggesting that ECMO patients might experience similar benefits. However, given the number of potential confounders and the cohorts coming from different time periods, it should be noted that clear cause and effect is difficult to ascertain in this case series. A key consideration in the application of ECMO with rehabilitation as a bridge to lung transplant is patient selection. All subjects in this report had single-organ failure and a limited course of critical illness; however, comorbidities, including diabetes, bacteremia, and malnutrition, were common. The degree of critical illness and organ dysfunction led to the referral of 2 of the rehabilitation cohort patients to our center, after being deemed excessively high-risk by other transplant centers. In each case it was believed that the patient's mortality approached 100% without initiation of ECMO as a bridge to transplantation. To optimize each patient's lung transplant candidacy, ECMO was initiated as early as possible following intubation, using a single cannulation site to allow for maximal mobility and to minimize deconditioning.
As transplantable organs are a rare and valuable resource, their utilization must be considered carefully. Two subjects in the rehabilitation cohort had bacteremia at the time of ECMO cannulation, and the expectation that infection had to be cleared prior to listing for lung transplant was made clear to the subjects' families prior to ECMO cannulation. Additionally, forthright discussions were held to ensure a clear understanding that listing for lung transplant was contingent upon successful rehabilitation on ECMO.
For the 5 subjects in this study rehabilitated while supported with ECMO, mean time to hospital discharge posttransplant is comparable to the general, non-critically-ill lung transplant population. 32, 33 Post-transplant stay for these subjects was notably shorter than previously reported for subjects supported with mechanical ventilation and/or non-awake ECMO prior to transplantation, 6, 31, 34 and potentially shorter than for subjects supported with awake ECMO prior to transplant. 13 Comparison between the outcomes of our study and the awake ECMO subjects reported by Fuehner et al is difficult, as that study used early application of ECMO prior to mechanical ventilation and associated deconditioning, and did not study the effects of active physical therapy and ambulation on this population. When compared to the non-critically-ill lung transplant population at our center, the rehabilitation cohort had similar duration of mechanical ventilation and ICU stay posttransplant, but slightly extended hospital stay.
Despite having longer pre-transplant mechanical ventilation and ECMO courses, subjects undergoing rehabilitation were better conditioned than the traditionally managed ECMO patients, as evidenced by the lack of neuromyopathy, improved post-transplant ambulation, and shorter time to ICU and hospital discharge. It seems counterintuitive that prolonged duration of life support for critically ill patients awaiting lung transplant could improve outcomes, but this active rehabilitation program represents a paradigm shift in the management of these complex patients. With a small population of subjects it is difficult to determine what effect this conditioning has on longterm outcomes; however, prior studies have shown a clear relationship between short-and long-term outcomes in lung transplant patients. 1, 32, 33, 35 Presumably, reducing posttransplant ICU and hospital stay will lead to fewer shortterm-complications and improved long-term outcomes.
Numerous safety concerns must be carefully considered before attempting to rehabilitate patients supported with ECMO. 14, 16, 21 Using a well coordinated multidisciplinary effort, the subjects in this study had no serious complications related to participating in physical therapy and rehabilitation while supported with ECMO. Several other centers have also reported successful ambulation in patients supported with ECMO, with minimal complications, both as a bridge to lung transplant and for other causes of respiratory failure. 14, 15, 21, 22 Another important consideration in implementation of a program of this nature is the amount of time spent on the waiting list for transplant. A relatively short wait time on the transplant list may be important for success in these patients, given the potential for increased complications related to the prolonged utilization of ECMO. However, in non-ambulatory ECMO patients, successful lung transplantation has been reported after 107 days of ECMO support. 36 Each of the subjects in this study received donor lungs within 14 days of being listed for transplant. While this shortened wait time is aided by the level of critical illness, our center's average wait time of 18 days is dramatically shorter than the 150 day average reported for all centers. 4 As such, the use of ambulatory ECMO as a successful bridge to lung transplant may not be easily generalizable to centers with longer average wait times.
As we continue to develop our ambulatory ECMO program, increased numbers of subjects will provide us with a better understanding of the potential benefits and risks of this approach. There are a number of clear challenges and risks associated with ambulating patients supported by ECMO, but the results of this study add to the growing number of reports supporting the safety of active physical conditioning provided by this novel strategy. Availability of a program of this nature may lead to reconsideration of the lung transplant candidacy of select critically ill patients and also change the overall approach to the management of critical illness in the setting of lung transplantation.
Conclusions
Bridging critically ill patients to lung transplantation with veno-venous ECMO is a viable treatment option for selected patients. When patients require ECMO support prior to lung transplant, active participation in physical therapy, including ambulation, may provide for a more rapid post-transplantation recovery.
